Big Pharma regained mojo in 2022 but biotechs remain precarious
03 Mar 2023 //
FIERCE BIOTECH
The potential blockbusters still awaiting FDA decisions in 2021
13 Sep 2021 //
FIERCEPHARMA
MMIT and Evaluate merge to become a $ 1.6 billion pharmaceutical market provider
29 Aug 2021 //
BUSINESSWIRE
Who`s getting the most out of their R&D engine? Pharma`s top 11, ranked
26 Aug 2021 //
FIERCE PHARMA
Top 11 most valuable R&D engines in pharma
24 Aug 2021 //
FIERCEPHARMA
Which pharma`s getting the most out of its new drug approvals?
23 Aug 2021 //
FIERCE PHARMA
MMIT and Evaluate Join Forces to Offer an End-to-End View of the Pharma Market
20 Aug 2021 //
BUSINESSWIRE
Evaluate Group Limited Appoints Cem Baydar as Chief Consulting Officer
21 Jun 2021 //
BUSINESSWIRE